CSF2 and myeloid sarcoma: Several studies have investigated the potential role of CSF cytokines and chemokines in MS, with the final aim of better clarifying the pathogenesis of the disease, suggesting biomarkers for diagnosis, prognosis, and eventually predicting the response to therapies (13).